LEAP-BIO event

LEAP-BIO is a partner in the Collaborative & Licensing Opportunities Presentations at BioFIT

LEAP-BIO project is currently seeking applicants, who own early-stage assets at the discovery or preclinical stage that match the licensing interests of big pharma and well-funded biotech companies.

Great opportunity for TTOs, universities, research institutes and start-ups is offered to showcase their promising early-stage assets in front of potential partners/ licensors in the pharmaceutical field, in order to entail licensing deals. Sciences.

APPLY
To apply to the Collaborative and Licensing Opportunity Presentations you must be registered to BioFIT.

To apply, the candidate must:

• Have an early-stage asset to entail a collaborative project and/or an opportunity to out-license
• Be registered to BioFIT 2023
• Fill out the online application form and submit it before September 28th, 2023

BE SELECTED

• All applications will be reviewed by a jury (composed of high level representatives and international experts from public and private institutions, life sciences industries, and investors) who will select the most promising early-stage assets.
• The selected projects will have the opportunity to be presented during BioFIT.
• The selected candidates will have the possibility to display a poster within the exhibition area during BioFIT.

PITCH & BE AWARDED

• The pitchers will have a 5 min timeslot during BioFIT to present and to highlight the most innovative aspects of their early-stage assets, in front of a jury of experts and potential partners.
• The pitchers will receive valuable feedback and advice from the panel of experts.
• The most innovative asset will be selected by the jury of experts and by the audience.
• The winner will be recognised during the 2nd day of BioFIT as the most promising early-stage technology in Europe in Life Sciences.